Insider Transactions Reported by 14 Insiders of Rubius Therapeutics, Inc.

Location
Foxboro, MA

There are no Buy or Sell transactions made by insiders since 08 Feb 2025

Rubius Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Francis M. Cuss Director 12 May 2022
Catherine A. Sohn Director 12 May 2022
Jonathan Symonds Director 12 May 2022
Jose Carmona Chief Financial Officer 31 Jan 2022
Maiken Keson-Brookes CLO & Corp. Secretary 29 Jan 2022
David R. Epstein Director 12 May 2022
Natalie C. Holles Director 12 May 2022
Anne Prener Director 12 May 2022
Dannielle Appelhans CEO and President 24 Feb 2023
Laurence A. Turka Chief Scientific Officer 29 Jan 2023
Susanne Schaffert Director 29 Jul 2022
PABLO J. CAGNONI Director 01 Feb 2023
Ph.D. Noubar B. Afeyan Director, 10%+ Owner 12 May 2022
Michael Rosenblatt Director 12 May 2022

Recent Insider Transactions by Companies or Individuals for Rubius Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.